Insmed Inc Stock In The News

INSM Stock  USD 25.81  0.54  2.14%   
The overall news coverage of Insmed Inc from major news outlets shows bullish sentiment on 9 news articles, blog posts, and TV commentaries analyzed in the last few months. Our overall analysis of Insmed's news coverage and content from conventional and social sources shows investors' bearish mood towards Insmed Inc. The specific impact of Insmed news on its stock price will depend on a range of factors, including the nature and significance of the news report and investors' perceptions of Insmed's overall financial health and prospects. It also depends on the type and quality of a news publisher.
  
Some academic researchers believe in a strong correlation between financial news and their impacts on the movements of stock prices. Macroaxis does not take a position on this subject and only provides tools that can help investors to time the market using Insmed headlines in addition to utilizing other, more conventional financial analysis modules. Check out Insmed Backtesting and Insmed Hype Analysis.

Insmed Today Top News and Investor Outlook

Yahoo News
What Makes Insmed (INSM) a Lucrative Investment?
https://finance.yahoo.com/news/makes-insmed-insm-lucrative-investment-164015756.html
 Bullish
Yahoo News
Insmed Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
https://finance.yahoo.com/news/insmed-reports-inducement-grants-under-130000208.html
 Bullish
Yahoo News
Insmed To Present at Three March Conferences
https://finance.yahoo.com/news/insmed-present-three-march-conferences-130000497.html
 Neutral
Yahoo News
Insmed Full Year 2023 Earnings: EPS Misses Expectations
https://finance.yahoo.com/news/insmed-full-2023-earnings-eps-130643095.html
 Neutral
Yahoo News
Insmed Incorporated (NASDAQ:INSM) Q4 2023 Earnings Call Transcript
https://finance.yahoo.com/news/insmed-incorporated-nasdaq-insm-q4-172350324.html
 Bullish
Yahoo News
Q4 2023 Insmed Inc Earnings Call
https://finance.yahoo.com/news/q4-2023-insmed-inc-earnings-033535099.html
 Bullish
Yahoo News
Insmed (INSM) Reports Q4 Loss, Misses Revenue Estimates
https://finance.yahoo.com/news/insmed-insm-reports-q4-loss-131005215.html
 Bullish
Yahoo News
Insmed Reports Fourth-Quarter and Full-Year 2023 Financial Results and Provides Business Update
https://finance.yahoo.com/news/insmed-reports-fourth-quarter-full-120000905.html
 Neutral
Yahoo News
Insmed (INSM) Expected to Beat Earnings Estimates: Should You Buy?
https://finance.yahoo.com/news/insmed-insm-expected-beat-earnings-150042375.html
 Bullish
Yahoo News
Insmed to Host Fourth-Quarter and Full Year 2023 Financial Results Conference Call on Thursday, February 22, 2024
https://finance.yahoo.com/news/insmed-host-fourth-quarter-full-130000922.html
 Bullish

Insmed Inc Past News Timeline

Popular news outlets such as MarketWatch, Bloomberg, or Reuters provide Insmed and other traded companies coverage. We help investors stay connected with Insmed headlines for the 25th of April to make an informed investment decision based on correlating the impacts of news items on Insmed Stock performance. Please note that trading solely based on the Insmed Inc hype is not for everyone as timely availability and quick action are needed to avoid losses.
Insmed's linear event process diagram shows some of the filtered current and past headlines as well as many other corporate-specific events such as SEC filings, dividends, and regulatory reporting available to the public. This module can help Insmed Inc investors visualize upcoming and past events in order to time the market based on Insmed Inc noise-free hype analysis.
Insmed stock price changes are notoriously difficult to predict based exclusively on its news coverage or social hype. Still, the Insmed earnings-per-share ratio is a good starting point for gauging a company's future prospects. If a firm's EPS rises and meets or even beats consensus forecasts, its shares stand to increase. However, some very sophisticated investors can spot management manipulation of EPS through actions such as buybacks.
Far too much social signal, news, headlines, and media speculation about Insmed that are available to investors today. That information is available publicly through Insmed media outlets and privately through word of mouth or via Insmed internal channels. However, regardless of the origin, that massive amount of Insmed data is challenging to quantify into actionable patterns, especially for investors that are not very sophisticated with ever-evolving tools and techniques used in the investment management field.
A primary focus of Insmed news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of Insmed relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to Insmed's headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive Insmed alpha.

Insmed Largest EPS Surprises

Earnings surprises can significantly impact Insmed's stock price both in the short term and over time. Negative earnings surprises usually result in a price decline. However, it has been seen that positive earnings surprises lead to an immediate rise in a stock's price and a gradual increase over time. This is why we often hear news about some companies beating earning projections. Financial analysts spend a large amount of time predicting earnings per share (EPS) along with other important future indicators. Many analysts use forecasting models, management guidance, and additional fundamental information to derive an EPS estimate.
Reported
Fiscal Date
Estimated EPS
Reported EPS
Surprise
2013-08-06
2013-06-30-0.32-0.280.0412 
2015-05-07
2015-03-31-0.5-0.55-0.0510 
2014-05-08
2014-03-31-0.41-0.360.0512 
2013-11-05
2013-09-30-0.41-0.46-0.0512 
2012-08-07
2012-06-30-0.33-0.39-0.0618 
2011-11-08
2011-09-30-0.28-0.34-0.0621 
View All Earnings Estimates

Insmed Stock Latest Headlines

Some academic researchers believe in a strong correlation between financial news and their impacts on the movements of stock prices. Macroaxis does not take a position on this subject and only provides tools that can help investors to time the market using conventional financial analysis. Below is the latest headlines and news related to Insmed Inc Stock. The global stock market is bearish. About 60% of major world exchanges and indexes are down. See today's market update for more information.
Investing News at Macroaxis
23rd of April 2024
Insmed shares upgraded on growth potential
at investing.com 
Google News at Macroaxis
16th of April 2024
Arizona State Retirement System Sells 657 Shares of Insmed Incorporated - Defense World
at news.google.com 
cnbc News
2nd of April 2024
Acquisition by Michael Smith of 58260 shares of Insmed at 29.13 subject to Rule 16b-3
at cnbc.com 
Google News at Macroaxis
14th of March 2024
Graham Capital Management L.P. Purchases 33969 Shares of Insmed Incorporated - Defense Wor...
at news.google.com 
Google News at Macroaxis
11th of March 2024
California State Teachers Retirement System Cuts Position in Insmed Incorporated - Defense...
at news.google.com 
Yahoo News
5th of March 2024
Insmed Reports Inducement Grants Under NASDAQ Listing Rule 5635
at finance.yahoo.com 
Google News at Macroaxis
1st of March 2024
FY2024 EPS Estimates for Insmed Incorporated Lowered by Cantor Fitzgerald - AmericanBankin...
at news.google.com 
Yahoo News
28th of February 2024
Acquisition by Melvin Sharoky of 1200 shares of Insmed subject to Rule 16b-3
at finance.yahoo.com 
Investing News at Macroaxis
22nd of February 2024
Insmed shares rise on Q4 revenue beat
at investing.com 

Insmed Investors Sentiment

The influence of Insmed's investor sentiment on the probability of its price appreciation or decline could be a good factor in your decision-making process regarding taking a position in Insmed. The overall investor sentiment generally increases the direction of a stock movement in a one-year investment horizon. However, the impact of investor sentiment on the entire stock market does not have solid backing from leading economists and market statisticians.
Investor biases related to Insmed's public news can be used to forecast risks associated with an investment in Insmed. The trend in average sentiment can be used to explain how an investor holding Insmed can time the market purely based on public headlines and social activities around Insmed Inc. Please note that most equities that are difficult to arbitrage are affected by market sentiment the most.
Insmed's market sentiment shows the aggregated news analyzed to detect positive and negative mentions from the text and comments. The data is normalized to provide daily scores for Insmed's and other traded tickers. The bigger the bubble, the more accurate is the estimated score. Higher bars for a given day show more participation in the average Insmed's news discussions. The higher the estimated score, the more favorable is the investor's outlook on Insmed.
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Insmed in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Insmed's short interest history, or implied volatility extrapolated from Insmed options trading.
When determining whether Insmed Inc is a strong investment it is important to analyze Insmed's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Insmed's future performance. For an informed investment choice regarding Insmed Stock, refer to the following important reports:
Check out Insmed Backtesting and Insmed Hype Analysis.
You can also try the Funds Screener module to find actively-traded funds from around the world traded on over 30 global exchanges.

Complementary Tools for Insmed Stock analysis

When running Insmed's price analysis, check to measure Insmed's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Insmed is operating at the current time. Most of Insmed's value examination focuses on studying past and present price action to predict the probability of Insmed's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Insmed's price. Additionally, you may evaluate how the addition of Insmed to your portfolios can decrease your overall portfolio volatility.
Instant Ratings
Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance
Bollinger Bands
Use Bollinger Bands indicator to analyze target price for a given investing horizon
Price Transformation
Use Price Transformation models to analyze the depth of different equity instruments across global markets
Premium Stories
Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope
Equity Forecasting
Use basic forecasting models to generate price predictions and determine price momentum
ETFs
Find actively traded Exchange Traded Funds (ETF) from around the world
Portfolio Suggestion
Get suggestions outside of your existing asset allocation including your own model portfolios
ETF Categories
List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments
Pattern Recognition
Use different Pattern Recognition models to time the market across multiple global exchanges
Competition Analyzer
Analyze and compare many basic indicators for a group of related or unrelated entities
Volatility Analysis
Get historical volatility and risk analysis based on latest market data
Sync Your Broker
Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors.
Is Insmed's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Insmed. If investors know Insmed will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Insmed listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(5.34)
Revenue Per Share
2.173
Quarterly Revenue Growth
0.411
Return On Assets
(0.28)
Return On Equity
(14.53)
The market value of Insmed Inc is measured differently than its book value, which is the value of Insmed that is recorded on the company's balance sheet. Investors also form their own opinion of Insmed's value that differs from its market value or its book value, called intrinsic value, which is Insmed's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Insmed's market value can be influenced by many factors that don't directly affect Insmed's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Insmed's value and its price as these two are different measures arrived at by different means. Investors typically determine if Insmed is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Insmed's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.